(Bloomberg) — CVS Health Corp. was accused in a lawsuit by pharmacy customers of intentionally overcharging for generic prescription drugs by submitting claims for payment to third parties at inflated prices.

Beginning in 2008, CVS orchestrated a "massive fraud that resulted in substantial ill-gotten gains," according to the complaint filed Thursday in San Francisco federal court. The drugstore chain sometimes charges three or four times the customary price for generic drugs, the customers said.

The lawsuit's allegations involve the company's Health Savings Pass, a discount program for patients paying cash for prescriptions. Customers who buy prescriptions through third-party plans pay higher prices than those paying cash, according to the complaint.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Cost-Containment